Fremont 2016 Webinar on Maintaining an Effective CAPA Program by Compliance4all
Sign up to be notified of new teleseminars daily! |
| Description: | Overview: CAPA programs are critical for any manufacturer. FDA considers your program the immune system for your site business unit and determines how healthy or unhealthy you are. Industry is now using various risk-based approaches and tools to set-up, deploy and maintain their CAPA programs to help with the decision making process. Understand the emphasis on analyzing processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned product, and other sources of quality data to identify existing and potential causes of nonconforming product, or other quality problems...and the use of appropriate statistical methodology where necessary to detect recurring quality problems. This session provides an overview on identifying recommended practices to improve, streamline, refine, retool…and develop, deploy and maintain a viable and sustainable CAPA system. Learn that a well written policy and procedure on setting up and maintaining your system is just the first part of the process…now you need to monitor your system because CAPA is your immune system and will determine how healthy or unhealthy or business site is. Areas Covered in the Session: How to use FMEA effectively and calculating Risk Priority Numbers: How to Use the Criteria How to facilitate a product complaint investigation as part of your CAPA program What is a closed-loop investigation…cradle to grave approach How to conduct an investigation using a well-written CAPA policy and procedure Understand and comprehend what FDA is looking for in meeting minimum expectations…no band-aid solutions Why risk assessment and risk-based approaches, FMEA, FTA, HACCP, etc., are now the expectation in terms of good business practice Establish a priority system as related to major versus minor or high risk versus low risk classifications…to support your decisions Develop and deploy escalation rules and criteria to facilitate decision-making process Understand what it takes to conduct a “quality” investigation to ascertain the root cause Review and discuss recent CAPA red flags and FDA enforcement actions Who Will Benefit: This webinar will provide valuable assistance and guidance to all regulated companies that are preparing to use or are currently using risk-based tools for CAPA investigations and closing out investigations in a timely manner. The employees who will benefit include: All levels of Management for all departments and those who desire a better understanding or a "refresh" overview QA/QC/CAPA Coordinators/CAPA Specialists Regulatory Affairs and Compliance Engineering/Technical Services/Operations Consultants Speaker Profile: David Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape. Read more at : http://www.compliance4all.com/control/w_product/~product_id=500834LIVE |
| URL: | http://www.compliance4all.com/control/w_product/~product_id=500834LIVE |
| Status: | Rejected |
| Date: | Wednesday, October 5, 2016 |
| Time: | 2:00pm-3:00pm UTC |
| Duration: | 1 hour |
| Access: | Public |
| Created by: | compliance4all |
| Updated: | Monday, August 29, 2016 7:03am UTC |
| : | $ 150.00 |
| : | 18004479407 |
| : | support@compliance4All.com |
| : | Event Manager |
| : | 800-447-9407 |
| Comments: | None |